Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lipopolysaccharide removal by a peptide-functionalized surface.

Anna Nilsson1, Camilla Fant, Magnus Nydén

  • 1Department of Materials and Surface Chemistry, Applied Surface Chemistry, Chalmers University of Technology, SE-412 96 Göteborg, Sweden. anilsson@chem.chalmers.se

Colloids and Surfaces. B, Biointerfaces
|January 12, 2005
PubMed
Summary

The CAP18(106-137) peptide demonstrates superior lipopolysaccharide (LPS)-binding capacity and stability for potential extracorporeal therapy. This research highlights its effectiveness in septic shock treatment development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antimicrobial Resistance in Children With Bloodstream Infections: A Population-Based Study in Stockholm, Sweden.

Acta paediatrica (Oslo, Norway : 1992)·2026
Same author

Dysregulation of the inside-out signaling pathway in CNS-infiltrated pediatric T-cell acute lymphoblastic leukemia.

Research square·2026
Same author

Including Research Subjects without Decision-Making Capacity Only as Last Resort.

Ethics & human research·2026
Same author

Inotuzumab ozogamicin in paediatric very high risk first B-cell acute lymphoblastic leukaemia relapse (ITCC-059): a multicentre, single-arm, phase 2 trial.

The Lancet. Haematology·2026
Same author

Re: Comment on "Socioeconomic Risk Factors for Incomplete Vaccination in Swedish Two-Year-Olds-A Nationwide, Population-Based Cohort Study".

Acta paediatrica (Oslo, Norway : 1992)·2026
Same author

Socioeconomic Risk Factors for Incomplete Vaccination in Swedish Two-Year-Olds-A Nationwide, Population-Based Cohort Study.

Acta paediatrica (Oslo, Norway : 1992)·2026

Area of Science:

  • Biochemistry
  • Biomaterials Science
  • Medical Technology

Background:

  • Lipopolysaccharide (LPS) is a major component of Gram-negative bacteria, contributing to septic shock.
  • Developing effective extracorporeal therapies to remove LPS is crucial for treating sepsis.
  • Peptides derived from LPS-binding molecules offer potential therapeutic agents.

Purpose of the Study:

  • To evaluate the lipopolysaccharide (LPS)-binding ability of five peptides for potential extracorporeal therapy.
  • To compare the binding efficacy and stability of different peptide immobilization methods.
  • To identify the most promising peptide for LPS removal in septic shock treatment.

Main Methods:

  • Surface Plasmon Resonance (SPR) was used to quantify LPS-peptide interactions.

Related Experiment Videos

  • Peptides were immobilized on dextran and poly(ethylene imine)-poly(ethylene glycol) (PEI-PEG) surfaces.
  • Binding efficacy and stability were assessed using various immobilization strategies.

    • Main Results:

    • CAP18(106-137) peptide exhibited the highest LPS-binding efficacy and stability across different immobilization methods.
    • Endotoxin Inhibitor (EI) peptide showed good binding capacity but less stable interaction.
    • Other peptides demonstrated significantly lower binding efficacy.
    • LPS binding to CAP18(106-137) was selective with minimal non-specific binding to the PEI-PEG surface.

    Conclusions:

    • The CAP18(106-137) peptide is a highly effective candidate for LPS removal in extracorporeal therapies.
    • Immobilization methods did not significantly impact CAP18(106-137) binding efficacy.
    • These findings support the development of novel extracorporeal treatments for septic shock.